HOME >> BIOLOGY >> NEWS
Enzyme may be target for new anti-inflammatory compounds

Virginia Commonwealth University researchers studying the enzyme that triggers inflammation have found that it may be a target for a new class of anti-inflammatory drugs to treat arthritis, asthma, multiple sclerosis, lung and colon cancers and Alzheimer's disease.

In the December issue of the Journal of Lipid Research, researchers examined the structural make-up of ceramide which is a target molecule for the enzyme known as ceramide kinase (CERK). CERK is able to recognize ceramide based on its structure. The interaction of CERK and ceramide is like a lock and key. They found that even a slight change in the structure of ceramide can significantly decrease CERK's ability to identify its target and catalyze the reaction.

"Our findings suggest that CERK could be a novel target for a new generation of anti-inflammatory/anti-trauma therapeutics, and lay the groundwork for a rationale design of inhibitors for CERK," said lead author Charles E. Chalfant, Ph.D., assistant professor of biochemistry at VCU.

According to Chalfant, CERK is responsible for catalyzing the process in mammals called phosphorylation that produces a signaling lipid called ceramide-1-phosphate (C1P). C1P is an important biological mediator that induces inflammatory pathways such as those blocked by many allergy medications.

"The inhibition of CERK would have the added benefit of shutting down the entire inflammatory pathway possibly alleviating side-effects caused by the medications such as Vioxx, which was recently withdrawn from the pharmaceutical market."


'"/>

Contact: Sathya Achia-Abraham
sbachia@vcu.edu
804-827-0890
Virginia Commonwealth University
2-Dec-2005


Page: 1

Related biology news :

1. Enzyme discovery sheds light on vitamin D
2. Enzyme delivered in smaller package protects cells from radiation damage
3. Enzyme Engineering XIX
4. Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
5. Enzyme shreds Alzheimers protein
6. Enzyme defect leads to hyperinsulinism
7. Eat less, weigh more? Enzyme makes lean mice susceptible to dietary fat
8. Enzyme crystal structure reveals unexpected genome repair functions
9. Enzyme inhibitors block replication of SARS virus
10. Enzyme action creates protein linked to Alzheimers disease
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... November 14, 2018 , ... ... management solutions, announced today that Prime Healthcare, a leading operator of over 50 ... requirements. , Persivia’s Bundled Payment solution consists of the industry’s only end ...
(Date:11/15/2018)... ... November 14, 2018 , ... ... MD, founder and medical director of Flatiron Functional Medicine to its Medical Advisory ... Dr. Carnahan will bring to uBiome extensive experience in treating the root causes ...
(Date:11/14/2018)... , ... November 14, 2018 , ... In recognition of ... help raise diabetes awareness and advocacy. The company is reaching out to help educate ... well as emphasize the importance of vision testing for people with the disease. , ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... (PRWEB) , ... November 08, 2018 , ... ... the United States, adopted a machine-learning powered approach to increasing recovery rates by ... around an Artificially Intelligent Collections (AIC) product developed by NLP Logix, a Jacksonville, ...
(Date:11/7/2018)... ... November 07, 2018 , ... Diversified Technologies, Inc. (DTI) has installed ... Center for Algae Technology and Innovation at ASU. Funded by a USDA NIFA SBIR, ... involved with algal and predator control applications. , Algae ponds get up to 50% ...
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD Holdings ... Siemens Healthineers and several healthcare VC firms announces at Distributed Health 2018 conference ... history by purchasing tokens and obtaining its first radiology interpretations, one of the ...
(Date:11/3/2018)... ... November 01, 2018 , ... Come to ... Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA will be ... data reliability. , What should clinical research industry stakeholders keep in mind when ...
Breaking Biology Technology:
Cached News: